Envestnet, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

Net Income (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of Reconciliation of the Numerators and Denominators Used in Computing Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders

The following table provides the numerators and denominators used in computing basic and diluted net income (loss) attributable to Envestnet, Inc., per share:


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2023		2022		2023		2022

	(in thousands, except per share and per share data)
Net income (loss) attributable to Envestnet, Inc.	$	7,091	$	(7,290)	$	(55,553)	$	(44,434)
Weighted average common shares outstanding:
Basic	54,562,270		55,226,777		54,380,231		55,109,387
Effect of dilutive shares:

Non-vested RSUs and PSUs	361,982		—		—		—
Options to purchase common stock	46,364		—		—		—

Diluted	54,970,616		55,226,777		54,380,231		55,109,387
Net income (loss) attributable to Envestnet, Inc., per share:
Basic	$	0.13	$	(0.13)	$	(1.02)	$	(0.81)
Diluted	$	0.13	$	(0.13)	$	(1.02)	$	(0.81)

Schedule of Anti-Dilutive Securities Excluded from Computation of Diluted Earnings per Share

Securities that were anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share were as follows:


	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2023	2022	2023	2022

Convertible Notes	10,811,884	9,898,549	11,176,254	9,898,549
Non-vested RSUs and PSUs	—	2,136,483	1,949,171	2,136,483
Options to purchase common stock	—	281,535	222,221	281,535
Warrants	—	470,000	—	470,000
Total anti-dilutive securities	10,811,884	12,786,567	13,347,646	12,786,567